Previous pathological studies have suggested that subcellular GPC3 localization may have distinct biological implications: membranous GPC3 expression has been linked to poor differentiation and microvascular invasion, whereas cytoplasmic expression has been linked to well-differentiated tumor histology and may reflect a more immune-accessible phenotype. This evidence concerns the gene GPC3 and neoplasm.